Tan T Y, Corden S, Barnes R, Cookson B
Department of Microbiology, Public Health Laboratory Service, University Hospital Wales, Cardiff, United Kingdom.
J Clin Microbiol. 2001 Dec;39(12):4529-31. doi: 10.1128/JCM.39.12.4529-4531.2001.
Methicillin-resistant Staphylococcus aureus septicemia is associated with significant morbidity and mortality and requires treatment with intravenous glycopeptides. For blood cultures positive for gram-positive cocci, 24 to 48 h is required for the detection of S. aureus bacteremia and the provision of antibiotic susceptibility testing results. We describe a molecular biology-based assay that requires 2 h from the time of initial positivity of blood cultures. The assay correctly detected 96% of the S. aureus isolates including all methicillin-resistant S. aureus isolates. Clinical data collected during the study suggest that 28% of patients with S. aureus bacteremia do not receive early and appropriate treatment and that 10% of patients may initially be receiving inappropriate glycopeptide treatment.
耐甲氧西林金黄色葡萄球菌败血症与显著的发病率和死亡率相关,需要静脉注射糖肽类药物进行治疗。对于革兰氏阳性球菌血培养阳性的情况,检测金黄色葡萄球菌菌血症并提供抗生素药敏试验结果需要24至48小时。我们描述了一种基于分子生物学的检测方法,从血培养初次阳性起只需2小时。该检测方法能正确检测出96%的金黄色葡萄球菌分离株,包括所有耐甲氧西林金黄色葡萄球菌分离株。研究期间收集的临床数据表明,28%的金黄色葡萄球菌菌血症患者未得到早期且恰当的治疗,10%的患者最初可能接受了不恰当的糖肽类药物治疗。